Physician profile
Anna L Pilzek
NPI 1083811186
$1,989.29
in general payments reported to CMS, 2019-2025
26 companies · $707 in 2025
The $707 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.19 · 2021: $23.85 · 2022: $608 · 2023: $107 · 2024: $515 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,329.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $649.17 | 2022-2024 | Axonics, Bulkamid |
| Immunitybio, INC. | $135.00 | 2024-2025 | |
| Valencia Technologies Corporation | $131.42 | 2025 | Ecoin Device Kit |
| Dendreon Pharmaceuticals LLC | $111.08 | 2024-2025 | Provenge |
| Merck Sharp & Dohme LLC | $108.32 | 2024-2025 | Keytruda, Zerbaxa |
| Ferring Pharmaceuticals INC. | $99.91 | 2024-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $87.54 | 2024-2025 | Gemtesa |
| Boston Scientific Corporation | $77.52 | 2024-2025 | Axonics, Advantage System |
| Janssen Biotech, INC. | $69.85 | 2025 | Erleada |
| C. R. Bard, INC. & Subsidiaries | $66.35 | 2024 | Bard Urinary Drainage Bag |
| Dentsply Ih Ab | $55.00 | 2023 | Lofric |
| Endo USA, INC. | $48.04 | 2024-2025 | Xiaflex, Aveed |
| Laborie Medical Technologies Corp. | $42.17 | 2021-2025 | Eclipse |
| Accord Healthcare, INC. | $40.70 | 2024-2025 | |
| Telix Pharmaceuticals | $35.17 | 2024 | Illuccix |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $31.09 | 2023 | Gelpoint V-Path |
| Allergan, INC. | $28.19 | 2019 | |
| Tempus Ai, INC | $27.25 | 2025 | Xt Cdx |
| Vertex Pharmaceuticals Incorporated | $22.56 | 2025 | |
| Abbvie INC. | $20.91 | 2023 | |
| Coloplast Corp | $19.93 | 2025 | |
| Novartis Pharmaceuticals Corporation | $19.42 | 2024 | |
| Pfizer INC. | $17.42 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.45 | 2024 | |
| Femselect INC. | $15.02 | 2024 | Enplace |
| Caldera Medical, INC | $14.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Pilzek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.